Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Open

Julia Lee
December 21, 2016

Market Update

Julia Lee
December 19, 2016

Market Update

Julia Lee
December 16, 2016

Market Update

Julia Lee
December 15, 2016

Market update 14 December

Julia Lee
December 14, 2016

Market Update

Julia Lee
December 12, 2016

Market Update

Julia Lee
December 5, 2016

Market Update

Julia Lee
December 2, 2016

Market Update

Julia Lee
December 1, 2016

2016 Overview

Julia Lee
November 28, 2016

Market Update

Julia Lee
November 17, 2016

Peter Quinton on Trump’s victory

Bell Direct
November 17, 2016